The first official clinical trial unfolded in 1747, under the gaze of James Lind. He was concerned about the scourge of scurvy and thus analysed a cohort of patients, in an attempt to establish an effective therapy for the wider population. It was a landmark moment for mankind and became the touchpaper for frenetic probing, pondering and pontification as trials became the norm.

It was a bold move by the Homo sapien species to advance a new realm of existential curiosity – leaving their predecessors and, indeed, the rest of the animal kingdom in the dust.  Humans were no longer accepting the hand they had been dealt – they wanted to alter the deck.

Clinical trials, however, have rarely been a true reflection of society or the subgroups therein that most require input into research. Too often participation has been overwhelmingly white, male and middle class or designed for people who can navigate mind-boggling inconvenience.

Leveraging the potential of trials is about upholding diversity and inclusivity – increasing representation among different ethnicities, sexualities, backgrounds, religions, socio-economic statuses and geographical locations.

All these factors are part of a wider reboot of which James Lind would surely approve. Patients are becoming the stakeholders and experts in their own future.

We are the most gifted species in the history of the universe – but proving it is a gift we must never take for granted.

Enjoy the magazine,

John Pinching
editor

PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com

Iona Everson / group managing editor
iona.everson@pharmatimes.com

Karl Equi / executive director
karl.equi@pharmatimes.com  

SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com

Luci Sargood / business manager
luci.sargood@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2023 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.